Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
Reset 

New Jersey Health Foundation Awards $50,000 Innovation Grant To Princeton University Researcher Advancing Hepatitis Treatments

NEW BRUNSWICK, N.J., Feb. 14, 2018 /PRNewswire-USNewswire/ -- New Jersey Health Foundation (NJHF) has awarded a $50,000 Innovation Grant to Alexander Ploss, Ph.D, assistant professor of Molecular Biology at Princeton University, announced James M. Golubieski, president of NJHF.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018

Lilly to Showcase New Data for Taltz® (ixekizumab) and Other Products Across Immunology Pipeline at AAD Annual Meeting

INDIANAPOLIS, Feb. 14, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced that it will present new data for Taltz(®) (ixekizumab), baricitinib and mirikizumab at the American Academy of Dermatology (AAD) annual meeting taking place Feb. 16-20, 2018, in San Diego, Calif.

... Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018

FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults

SILVER SPRING, Md., Feb. 14, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI), commonly referred to as concussion, in adults. The FDA reviewed and authorized for marketing the... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint

SILVER SPRING, Md., Feb. 14, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant).... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Inaugural Rare Disease Patient Advocacy Guidelines Published

PHILADELPHIA, Feb. 14, 2018 /PRNewswire/ -- Susan Stein, MPH, CEO and Founder of the award-winning Connexion Healthcare, has announced the open-access publication of rare disease patient advocacy guidelines for interaction... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Alejandro J. Betancourt, M.D., FAANS, FACS, is recognized by Continental Who's Who

BROWNSVILLE, Texas, Feb. 14, 2018 /PRNewswire/ -- Alejandro J. Betancourt, M.D., FAANS, FACS, is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Neurological Medicine.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018

Elissa Jeanne Santoro, M.D., FACS, is recognized by Continental Who's Who

LIVINGSTON, N.J., Feb. 14, 2018 /PRNewswire/ -- Elissa Jeanne Santoro, M.D., FACS, is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Medicine in recognition of her role as a Breast Surgical Oncologist at RWJSBarnabas Health the Center for Breast Health and Disease... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Safe Rx adds Sales and Marketing Executives Andy Cipra & Rick Meckstroth

GREENWOOD VILLAGE, Colo., Feb. 14, 2018 /PRNewswire/ -- Safe Rx LLC is announcing the appointment of Andy Cipra to the role of Chief Commercial Officer and Rick Meckstroth to Vice President of Business Development.

Read more ››
By: PR Newswire Association LLC. - 14 Feb 2018
Related companies:  Safe Equine Technologies, Inc. | Alliance for Safe Biologic Medicines

Tony Boselli's In-School Flu Vaccination Program Ensures No Child Is Left Behind in This Year's Flu Epidemic with Surge in Demand for Vaccinations

JACKSONVILLE, Fla., Feb. 14, 2018 /PRNewswire/ -- Healthy Schools LLC, the largest provider of in-school flu vaccinations in Florida and Texas, reports an uncharacteristic surge in demand for flu shots this season with a need so great that some districts are holding second mid-season district-wide... Read more ››

By: PR Newswire Association LLC. - 14 Feb 2018

Hydropothecary signs letter of intent to supply Québec market

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018

Microbix Reports Record First Quarter Sales

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Microbix Biosystems Inc.

G1 Therapeutics to Report Fourth Quarter and Full-Year 2017 Financial Results on February 21, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  G1 Therapeutics, Inc.

AxoGen, Inc. to Report Fourth Quarter and Full-Year 2017 Financial Results and Host Conference Call on February 28, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  AxoGen, Inc.

Midatech Pharma Plc: Trading update

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Midatech Pharma Plc

Agios Reports Fourth Quarter and Full Year 2017 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Agios Pharmaceuticals, Inc.

Shire plc : Final Results

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018

Intercept Pharmaceuticals Reports Full Year and Fourth Quarter 2017 Financial Results and Provides Business Update

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Intercept Pharmaceuticals Inc.

Alimera Sciences to Report Fourth Quarter and Full Year 2017 Results on February 28, 2018

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Alimera Sciences, Inc.

Inovalon Announces Fourth Quarter and Full Year 2017 Earnings Conference Call

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  Inovalon

Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures

Read more ››
By: Nasdaq / GlobenewsWire - 14 Feb 2018
Related companies:  ABIOMED, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑